CE For Pharmacists


A Pharmacist's Guide to Tailored Therapy

An 8-hour advanced training to help pharmacists master both the science behind pharmacogenomics (PGx) and implement PGx testing that is now critical in delivering high quality patient care.

This course will take you through the basics of genetic definitions through understanding how to communicate with your patients the PGx results

Pharmacists by taking this course you will

Help patients with: 

  • Experiencing less side effects 
  • Personalizing their medicine choice 
  • Tailoring approach to targeted drug therapy 
  • Individualizing medication dosages 
  • Ensuring patients receive the correct medication
  • And one that will work for their genetic profile

Help your career by: 

  • Expanding your scope of practice 
  • Providing more services 
  • Elevating your value to prescribers 
  • Advancing patient care 
  • Providing tech advances in current day medicine 

Pharmacogenomics: A Pharmacist's Guide to Tailored Therapy

Inside this course, learn how to communicate the value of testing, shift medication goals based on results of PGX testing, and work with prescribers on how to use these tests to improve patient outcomes. 

Discover how personalized medicine can have an impact on patient outcomes with this online on-demand 8-hour comprehensive pharmacogenomics training course for pharmacists.

Gain a better understanding of the relationship between genetics and drug response, explore cutting-edge research, review how genetic variations affect drug metabolism, and discuss practical insights for implementing pharmacogenomics into pharmacy practice.

Revolutionize your pharmacy career by mastering the science behind pharmacogenomics to provide individualized care and optimize patient outcomes.

Meet Your Expert Faculty

D. Max Smith, PharmD, BCPS
Clinical Pharmacogenomics Specialist MedStar Health Assistant Professor Georgetown University
Dr. D. Max Smith, PharmD, BCPS is a Clinical Pharmacogenomics Specialist at MedStar Health and Assistant Professor at Georgetown University Medical Center. Dr. Smith earned a PharmD at the University of Toledo and is a board-certified pharmacotherapy specialist. At the University of Florida, he completed a PGY-1 hospital residency and completed a PGY-2 residency and fellowship specializing in pharmacogenetics. His overarching research interest is studying implementation and clinical outcomes from the application of pharmacogenetic information in prescribing decisions. In his current role, he facilitates implementation and oversight of clinical pharmacogenetic testing throughout MedStar Health. He also provides an electronic PGx consult service throughout MedStar Health.
Emily Loudermilk, PharmD, MS, BCPS
Operational/Clinical Pharmacist OhioHealth
Emily Loudermilk is a pharmacist with OhioHealth. She attended pharmacy school at Ohio Northern University then completed PGY1 residency with Marshall University and King’s Daughters Medical Center in Ashland, Kentucky. In addition to aiding with multiple pharmacogenomics publications, she recently completed her MS Pharmacogenomics at Manchester University.
Behnaz Sarrami, MS, PharmD
Director of Consulting Missouri Pharmacogenomics Consulting, LLC
Behnaz Sarrami is a pharmacist and the director of consulting at Missouri Pharmacogenomics Consulting, where genomics information is used to personalize medication therapy. Behnaz has over 15 years of experience in healthcare and has led many educational seminars for patients. She also acts as a clinical research consultant and part of a grant with Washington University Medical School, visiting homes of older adults who are homebound to help manage their medications. She is the author of many articles published in professional magazines and the Washington University medical blog. She serves as an editorial advisory board member for Pharmacy Today Magazine and has authored multiple accredited CE for both pharmacists and physicians.
John A. Galdo, PharmD, MBA, BCPS, BCGP
CEO Seguridad, Inc. Managing Network Facilitator CPESN Health Equity
Jake Galdo is a co-founder and CEO of Seguridad. Seguridad’s Choose My Pharmacy develops and implements quality measures specified to evaluate the quality and safety of a community pharmacy. Additionally, Dr. Galdo is the Lead Network Facilitator for CPESN Health Equity, a Special Purpose Network of CPESN focused on addressing health-related disparities. He is also a consultant with the Enhanced Service Pharmacy Alliance which specializes in delivery health equity services and practice transformation to local communities. He also spends his professional time staffing in a neighborhood community pharmacy, developing innovative clinical services, and representing the profession of pharmacy on various boards and advisory committees for regional and national organizations.

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe the pharmacists’ role in pharmacogenomics (PGx)
2. Discuss the state of PGx implementations across the industry
3. Recognize basic mechanisms for genetic variation to impact medications
4. Describe the standard nomenclature used in PGx
5. Compare and contrast different types of genetic tests
6. Provide specific examples that establish the relationship between altered drug disposition and genetic variants
7. Describe how PGx can be utilized to predict an individual’s response to drug therapy
8. Detail ethical, legal, and social issues (ELSI) and regulatory concerns surrounding PGx testing
9. Review regulatory activity, especially FDA guidance and rulemaking, impacting PGx
10. Describe the potential limitations of PGx testing
11. Describe the role of various PGX resources available to support clinical application
12. Discuss strategies to identify whether a drug-gene pair is ready for clinical use
13. Recognize the value that PGx can bring to patient care

14. Develop a pharmacotherapy regimen based on patient PGX results and characteristics
15. Create PGx therapeutic guidelines for selected drugs using a specified framework
16. Utilize clinical decision support tools to inform therapeutic recommendations
17. Apply guidelines and other evidence to patient cases across multiple medical specialties and subspecialities (e.g., behavioral health, cardiology, oncology, pain management)
18. Identify the impact of ancestry on PGx variant frequencies
19. Discuss the roles and responsibilities of clinical laboratories
20. Describe criteria for selecting a PGx laboratory
21. Compare and contrast provider-ordered clinical PGx lab testing vs direct-to-consumer genetic testing
22. Detail the key components required in a PGx test for clinical practice
23. Describe utilization of PGx in terms relevant for healthcare providers and payors
24. Identify strategies to develop and deliver PGx recommendations to prescribers
25. Explain genetic testing and its role in health care to patients
26. Describe important counseling points for PGx testing